Search Within

Gunjan Lalitchandra Shah

Formats
  1. Meeting Abstract (272)
  2. Journal Article (124)
  3. Research Letter (13)
  4. Review (6)
  5. Correspondence (2)
  6. Guidelines (1)
Groups
  1. Bone Marrow Transplant (418)
  2. Center for Hematologic Malignancies (418)
  3. Department of Medicine (418)
  4. Hematologic Malignancies, Division of (418)
  5. Survivorship Research (418)
  6. CTCR Scholars (321)

More Groups

People
  1. Sergio Giralt (297)
  2. Michael Scordo (277)
  3. Miguel-Angel Perales (192)
  4. Sean Devlin (177)
  5. Parastoo Dahi (155)
  6. Heather Landau (154)

More People

Years
  1. 2025 (12)
  2. 2024 (54)
  3. 2023 (85)
  4. 2022 (55)
  5. 2021 (31)
  6. 2020 (51)

More Years

Publications
  1. Blood (137)
  2. Biology of Blood and Marrow Transplantation (73)
  3. Clinical Lymphoma, Myeloma and Leukemia (39)
  4. Transplantation and Cellular Therapy (23)
  5. Blood Advances (20)
  6. Bone Marrow Transplantation (19)

More Publications

Publishers
  1. American Society of Hematology (157)
  2. Elsevier Inc. (142)
  3. Nature Publishing Group (31)
  4. American Society of Clinical Oncology (14)
  5. Taylor & Francis Group (9)
  6. Wiley Blackwell (7)

More Publishers

Results (418)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • "Defining the optimal post-CART monitoring period in recipients of axicabtagene ciloleucel and tisagenlecleucel"
    Meeting Abstract

    Wesson, W.; Lutfi, F.; Porter, D. L.; Bachanova, V.; Nastoupil, L. J.; Riedell, P. A.; Perales, M. A.; Maziarz, R. T.; Brower, J.; Shah, G. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with primary mediastinal B-cell lymphoma refractory or relapsed after frontline R-EPOCH chemotherapy
    Meeting Abstract

    Bakos, J.; Escribano Serrat, S.; Sawalha, Y.; Moskowitz, A.; Crawford, A.; Brooks, T. R.; Hill, B. T.; Falade, A. S.; Merryman, R. W.; Kamdar, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comparison of bendamustine versus fludarabine/cyclophosphamide lymphodepletion in adult patients receiving CD19 CAR-T cell therapy
    Meeting Abstract

    Landego, I.; Nemirovsky, D.; Devlin, S. M.; Wills, B.; Parascondola, A.; Saldia, A.; Dahi, P. B.; Tomas, A. A.; Ip, A.; Suh, H. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patterns and safety of glucocorticosteroids use following CD19 CAR-T cell therapy for B-cell lymphoma
    Meeting Abstract

    Luttwak, E.; Flynn, J. R.; Devlin, S. M.; Cassanello, G.; Corona, M.; Dahi, P. B.; Luna De Abia, A.; Fein, J.; Giralt, S. A.; Landego, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The impact of cardiovascular vulnerabilities in non Hodgkin lymphoma patients treated with chimeric antigen receptor T cell therapy
    Meeting Abstract

    Landego, I.; Flynn, J. R.; Goldman, A.; Devlin, S. M.; Luttwak, E.; Luna De Abia, A.; Corona, M.; Kedmi, M.; Sdayoor, I.; Fried, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • First fever between lymphodepletion and day 30 after CAR-T cell therapy: Patterns, origins, and implications in lymphoma patients
    Meeting Abstract

    Melica, G.; Luna, A.; Fei, T.; Corona, M.; Dahi, P. B.; Fein, J.; Giralt, S. A.; Raj, S.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Detection of CAR-T cell persistence with digital droplet PCR: Correlation of in vivo expansion with clinical outcomes in a cohort of B-cell lymphoma patients
    Meeting Abstract

    Cassanello, G.; Borsu, L.; Arcila, M. E.; Yao, J.; Boroujeni, A. M.; Ewalt, M.; Patel, U.; Chan, R.; Gray, B.; Luna De Abia, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • From widespread to tailored antifungal prophylaxis in lymphoma patients treated with CD19 CAR T- cell therapy: Less is better
    Meeting Abstract

    Melica, G.; Luna De Abia, A.; Corona, M.; Fein, J.; Dahi, P. B.; Giralt, S. A.; Landego, I.; Lin, R. J.; Palomba, M. L.; Parascondola, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of response to systemic bridging therapy on clinical outcomes and cytokine profiles in patients receiving CD19-CAR T-cell therapy for B-cell lymphoma
    Meeting Abstract

    Wills, B.; Shouval, R.; Flynn, J. R.; Devlin, S. M.; Parascondola, A.; Saldia, A.; Imber, B. S.; Tomas, A. A.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Post-transplant pain and paralysis: Neurologic amyotrophy as an atypical cause of shoulder dysfunction following hematopoietic stem cell transplant
    Meeting Abstract

    Davidoff, C.; Ibanez, K.; Hwang, S.; Goldstein, I.; Feldman, D. R.; Gyurkocza, B.; Giralt, S. A.; Politikos, I.; Ponce, D. M.; Scordo, M.; more...
    Blood (2023)

    Fulltext@MSK | Save